Overview
Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
Status:
Completed
Completed
Trial end date:
2011-06-01
2011-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The long-term outcomes of branched-chain amino acid (BCAA) administration in patients undergoing hepatic resection remain unclear. The aim of this study is to assess the impact of oral supplementation with BCAA on the prevention for the development of liver tumorigenesis in patients undergoing liver resection.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Kochi University
Criteria
Inclusion Criteria:- These patients were scheduled for elective liver resection to treat hepatocellular
carcinoma or adenocarcinoma of the liver.
Exclusion Criteria:
- a body-weight loss greater than 10% during the 6 months prior to surgery,
- the presence of distant metastases, or
- serious impairment of organ function due to respiratory, renal, or heart disease.